Ozempic-producer Novo Nordisk on track for record spending on lobbying in 2024
4 months, 4 weeks ago

Ozempic-producer Novo Nordisk on track for record spending on lobbying in 2024

Raw Story  

This article originally appeared in OpenSecrets. Novo Nordisk — the pharmaceutical giant behind popular weight-loss drugs Ozempic and Wegovy — spent a record $3.2 million on lobbying in the first six months of 2024 as the Denmark-based company expanded its footprint in the United States. In 2017, after two years of clinical trials, the Food and Drug Administration approved Novo Nordisk’s injectable weight-loss drug Ozempic strictly for adults with Type 2 diabetes. These drugs rose in popularity in 2023 as Novo Nordisk launched an aggressive advertising campaign, spending a total of $471 million to market Ozempic and Wegovy in one year. In June, Sen. Sanders threatened to subpoena Novo Nordisk CEO Lars Fruergaard Jorgensen, criticizing Novo Nordisk’s high American price tag on Ozempic when it is significantly lower in other countries.

Medicare Drugs Diabetes Patients Ozempic Novo Nordisk Wegovy Novo Nordisk 2023 2024  spending  track  nordisk  drugs  ozempicproducer  wegovy  2023  2024  record  ozempic  patients  lobbying  diabetes  weightloss  novo  million

History of this topic

Dr. Oz May Have Broken Influencer Marketing Rules
2 weeks, 6 days ago

Dr. Oz May Have Broken Influencer Marketing Rules

Huff Post  

Mehmet Oz, the television-personality doctor and Donald Trump’s pick to lead the Centers for Medicare & Medicaid Services, pitched herbal supplements and other products to his millions of social media followers without properly disclosing that he had a business relationship with the company selling them, according to a letter published Tuesday. Oz pitched iHerb’s ashwagandha capsules just a few days …

Eli Lilly and Novo Nordisk’s obesity moat just got stronger
3 weeks, 2 days ago

Eli Lilly and Novo Nordisk’s obesity moat just got stronger

Live Mint  

The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. Not only did MariTide fail to outperform Lilly’s Zepbound, but both Lilly and Novo also have next-generation medications under development, with promising data showing even more impressive weight loss results. “A 20% weight loss would have been best-in-class if …

Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices
1 month ago

Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices

Salon  

Semaglutide and tirzepatide medications have transformed weight loss, diabetes management, and overall health in recent years. According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market, where more than 180 million people live with obesity. Eli Lilly, Novo Nordisk’s direct competitor and the manufacturer of …

Weight-loss drug Wegovy launched in China
1 month ago

Weight-loss drug Wegovy launched in China

CNN  

Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity. Novo gained approval for Wegovy in China in June and will initially target Chinese patients willing to pay out-of-pocket for the weekly injectable drug. Strong sales there and in the …

Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage
1 month, 3 weeks ago

Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug
54 years, 11 months ago

The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug

Wired  

Drugmaker Novo Nordisk is taking action to curb the massively popular compounded semaglutide industry, which provides copies of its blockbuster weight-loss drugs Ozempic and Wegovy to patients—often for much lower prices. The Danish pharmaceutical company is lobbying the US Food and Drug Administration to add semaglutide to the agency’s Demonstrable Difficulties for Compounding lists, which would block compounding pharmacies from …

Eli Lilly is gaining on Novo Nordisk in the obesity race
4 months, 2 weeks ago

Eli Lilly is gaining on Novo Nordisk in the obesity race

Live Mint  

The two companies’ divergent earnings reports this week showed that Indianapolis-based Lilly is moving faster than its Denmark-headquartered counterpart in the race to win the GLP-1 war. Less than a year after approval, Eli Lilly’s weekly prescription volume of Zepbound is about where Novo was with Wegovy volume more than two years in, according to JPMorgan data. And while all …

Wegovy: Ozempic sister drug to be sold in Australia within days
4 months, 3 weeks ago

Wegovy: Ozempic sister drug to be sold in Australia within days

Daily Mail  

A drug that mimics popular weight loss medicine Ozempic will be available in Australian pharmacies within days. Like Ozempic, the drug is administered through a once-weekly pen, however it contains a higher amount of the active ingredient and is used to manage chronic weight conditions, whereas Ozempic is only approved to manage type 2 diabetes. In May the Australian government …

Surging demand, soaring price tags lead to fake Ozempic doses
4 months, 3 weeks ago

Surging demand, soaring price tags lead to fake Ozempic doses

Al Jazeera  

A rise in counterfeit versions of sought-after weight loss drug has led to a series of hospitalisations. The cost has fuelled some concerns in Washington with Senator Bernie Sanders calling Novo Nordisk’s price tag “outrageous”. What remains constant is the indisputable value and cost savings Novo Nordisk medicines bring to patients, healthcare systems and society,” a Novo Nordisk spokesperson told …

Weight-loss war heats up as Wegovy rival found to lead to faster and greater results
5 months, 2 weeks ago

Weight-loss war heats up as Wegovy rival found to lead to faster and greater results

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please …

Wegovy weight-loss drug OK'd in China
5 months, 4 weeks ago

Wegovy weight-loss drug OK'd in China

China Daily  

FILE PHOTO: A view shows the logo of Novo Nordisk at the company's office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, March 8, 2024. Danish drugmaker Novo Nordisk said Tuesday that its injectable weight-loss drug Wegovy has been approved in China, where the proportion of overweight and obese adults reached almost 51 percent of the country's 1.4 billion people …

Wegovy: At least 25,000 people in the US are starting weight-loss drug each week, drugmaker says
7 months, 3 weeks ago

Wegovy: At least 25,000 people in the US are starting weight-loss drug each week, drugmaker says

CNN  

CNN — Drugmaker Novo Nordisk said it’s been increasing supply of its sought-after weight-loss drug Wegovy, with at least 25,000 people now starting to take the medicine each week in the United States. We’re talking about, many patients, chronic treatment.” Eli Lilly, Novo Nordisk’s biggest competitor, also said this week it expects supply to increase later this year. “While we …

The Ozempic Effect: How a Weight Loss Wonder Drug Gobbled Up an Entire Economy
7 months, 3 weeks ago

The Ozempic Effect: How a Weight Loss Wonder Drug Gobbled Up an Entire Economy

Bloomberg  

There is no escaping Ozempic and Wegovy. They’ve won over the rich and famous, generated billions in sales and blown open a new market for weight loss drugs, which Goldman Sachs estimates will reach $100 billion a year by 2030. The development of semaglutide, the key ingredient in the medicines, has also transformed their maker, Novo Nordisk, into Europe’s most …

Ozempic, Wegovy: Sanders launches Senate investigation into ‘outrageously high’ pricing of drugs
8 months ago

Ozempic, Wegovy: Sanders launches Senate investigation into ‘outrageously high’ pricing of drugs

CNN  

CNN — Sen. Bernie Sanders is taking aim at the high prices of the blockbuster drugs Ozempic and Wegovy. The Vermont senator, an independent who has long called out drug manufacturers for their costly products, is launching an investigation into the “outrageously high prices” Novo Nordisk charges for the drugs. “Further, if the prices for these products are not substantially …

Ozempic, Mounjaro and hundreds of other drugs become even more expensive in 2024
10 months, 1 week ago

Ozempic, Mounjaro and hundreds of other drugs become even more expensive in 2024

CNN  

New York CNN — Some Americans may have to shell out more this year for Ozempic and Mounjaro, two wildly popular diabetes medications also used for weight loss. For most Americans, the price they pay for medications depends on their health insurance policies, not drugmakers’ list prices. While employers and commercial insurers are more likely to cover GLP-1 drugs like …

Novo Nordisk pays $25.8 million to promote its obesity drug
1 year ago

Novo Nordisk pays $25.8 million to promote its obesity drug

Live Mint  

During his address, Dr. Lee Kaplan urged fellow doctors to use their prescription pads to fight the obesity crisis, according to a report by Reuters on December 1. Dr. Kaplan, a leading U.S. weight-loss specialist, recommended turning to new weight-loss medicines like Novo Nordisk's Wegovy to reduce obesity. “We are going to have to use these medications,” he said at …

AstraZeneca joins obesity drug craze as it signs £1.6bn deal with Chinese medical group
1 year, 1 month ago

AstraZeneca joins obesity drug craze as it signs £1.6bn deal with Chinese medical group

Daily Mail  

AstraZeneca has entered the race to develop a weight-loss drug after striking a £1.6billion deal with a Chinese medical group. China deal: AstraZeneca boss Pascal Soriot said that the move into weight loss drugs follows 'enormous need around the world' Details emerged just hours after it was revealed that AstraZeneca is facing a multi-million-pound legal battle over claims the efficacy …

Obesity drug Wegovy reduces heart attacks and strokes risk by 20%, shows study
1 year, 4 months ago

Obesity drug Wegovy reduces heart attacks and strokes risk by 20%, shows study

Hindustan Times  

Novo Nordisk A/S shares surged to a record after the Danish company’s blockbuster obesity medicine Wegovy reduced the risk of heart attacks and strokes in a highly anticipated study, giving it another potential boost. Obesity drug Wegovy reduces heart attacks and strokes risk by 20%, shows study Patients with obesity or overweight and with a history of cardiovascular issues taking …

FDA warns consumers not to use off-brand versions of Ozempic, Wegovy
1 year, 6 months ago

FDA warns consumers not to use off-brand versions of Ozempic, Wegovy

Associated Press  

The U.S. Food and Drug Administration is warning consumers not to use off-brand versions of the popular weight-loss drugs Ozempic and Wegovy because they might not contain the same ingredients as the prescription products and may not be safe or effective. Agency officials said this week that they have received reports of problems after patients used versions of semaglutide, the …

Maker of fat-loss drugs Wegovy and Ozempic says shortages will be fixed in weeks
1 year, 10 months ago

Maker of fat-loss drugs Wegovy and Ozempic says shortages will be fixed in weeks

Daily Mail  

The maker of pharmaceutical blockbuster Wegovy for weight loss expects shortages to be resolved in the next few months as it ramps up production. An increase in demand combined with manufacturing hiccups caused a contraction in the supply chain last year, leaving behind a shortage of both Wegovy and its sister drug Ozempic. There has been such high demand that …

Novo Nordisk Statement to 60 Minutes
1 year, 11 months ago

Novo Nordisk Statement to 60 Minutes

CBS News  

Promising new weight loss medication in short supply and often not covered by insurance | 60 Minutes Prior to 60 Minutes', January 1, 2023, broadcast which featured correspondent Lesley Stahl's story on obesity, we reached out to Novo Nordisk, the maker of Wegovy and Ozempic about recent shortages of the medications. The company told 60 Minutes the following: Ozempic The …

Doctors explain how Wegovy and Ozempic work
1 year, 11 months ago

Doctors explain how Wegovy and Ozempic work

CBS News  

Anti-obesity drugs are growing in popularity in the United States as a greater number of Americans are being diagnosed with obesity than ever before. In the video above, Dr. Caroline Apovian, a weight management specialist at Brigham and Women's Hospital in Boston, who consults for Novo Nordisk, explains how the medications work. While reporting this story, 60 Minutes learned that …

Discover Related